About Avance Clinical
Avance Clinical is a premier CRO specializing in delivering a wide range of clinical trial execution services. Our expertise is deeply rooted in understanding the complexities of various cancer types and the corresponding clinical research landscape. This positions us uniquely to offer services that effectively address the specific needs of oncology trials.
Our Approach
Avance Clinical is committed to a solution-oriented, flexible, and agile approach in our service delivery. This strategy enables us to adeptly handle the unique demands of clinical trials in cancer research, integrating state-of-the-art technologies and methodologies to enhance trial design and execution while responding with precision to the intricacies of this field.
Gabriel Kremmidiotis, Chief Scientific Officer at Avance Clinical, emphasizes, “Our approach is tailored to meet the specific needs of each trial, ensuring scientific rigor and operational excellence at every stage.”
Consultation And Innovative Trial Designs
Our team provides expert consultation focused on the scientific and regulatory intricacies specific to cancer research. We ensure that trials are not only compliant with global standards but are also strategically positioned to yield successful outcomes. Avance Clinical supports a range of oncology trial designs, including:
- Phase 0 Trials: Small exploratory studies focusing on pharmacokinetics and pharmacodynamics to quickly assess how a drug behaves in the human body.
- Phase 1 Trials: Utilizing designs such as the traditional 3+3 and Bayesian Optimal Interval (BOIN) for dose escalation to establish safety profiles and optimal dosing parameters.
- Randomized Controlled Trials: Gold standard trials for assessing efficacy through randomized assignments of participants to experimental or control groups.
- Single-Arm Trials: Trials where all participants receive the experimental therapy, useful for initial efficacy evaluations.
- Adaptive Trials: Flexible trials that adjust parameters based on interim data to refine outcomes and methodologies.
- Basket Trials: Evaluate the effect of drugs across multiple tumor types based on shared mechanisms of action.
- Sequential Trials: Designed to assess and decide on the continuation of the study as data accumulates, allowing for adjustments based on initial findings.
Transitional Strategies
Avance Clinical specializes in guiding clients through critical transitional phases of drug development. Our ClinicReady strategy assists clients in moving from preclinical stages to first-in-human trials, ensuring a seamless and effective transition by addressing all scientific, regulatory, and operational aspects. Our GlobalReady strategy supports clients from first-in-human trials through to proof-of-concept trials, preparing for global mid to Late phase trials with comprehensive planning and execution strategies that cater to international standards and multi-regional clinical operations.
Clinical Management Expertise
Our clinical operations services ensure the flawless execution of trials, focusing on clinical site management, monitoring services, and project management. We manage operations at clinical sites to ensure operational excellence and compliance, implement meticulous monitoring protocols to ensure data accuracy and reliability, and deliver trials on schedule and within budget, facilitated by seasoned project managers.
Kremmidiotis states, “Our clinical management expertise ensures that trials are executed with precision, maintaining the highest standards of quality and compliance.”
Data Excellence And Quality Oversight
Where precision and accuracy are paramount, Avance Clinical upholds the highest standards for data integrity. Our in-house team develops and maintains sophisticated eCRF/EDC databases based on the highest quality industry platforms, ensuring rigorous data management tailored to cancer research. Our comprehensive data services include specialized statistical methodologies by our biostatisticians and pharmacokinetics to focus on optimizing therapeutic efficacy and dosing in treatments.
Access To Specialized Networks
We maintain strong collaborations with leading cancer research experts and specialized centers. This network enhances our service offerings and ensures access to pioneering research and high-quality investigators, supporting our commitment to advancing global cancer research. “Our collaborations with specialized networks allow us to integrate the latest research advancements and high-quality expertise into our trials,” Kremmidiotis explains.
Advancing Oncology Projects With Avance Clinical
Clinical research in oncology is rapidly evolving, driven by cutting-edge technologies and a deeper understanding of cancer biology. At Avance Clinical, we ensure that our execution of services is at the forefront of these advancements. This includes implementing partnerships and workflows to facilitate the application of precision medicine approaches, tailoring treatments based on individual genetic profiles, and adopting artificial intelligence tools to optimize clinical trial design and execution.
Furthermore, our focus on regulatory and logistics nuances associated with emerging advanced therapies, such as immunotherapy, including new checkpoint inhibitors and CAR-T cell therapies, positions us at the forefront of supporting biotechnology companies in the advancement of such treatment modalities currently changing the landscape in oncology clinical research.
Conclusion
For US biotechs developing oncology therapies, partnering with Avance Clinical offers a strategic advantage. With our deep scientific knowledge, extensive experience, and commitment to innovation, we provide a comprehensive suite of services that ensure the successful execution of oncology trials from early to late phases. Our solution-oriented approach, expert consultation, and robust clinical management capabilities position us as a leader in oncology clinical research.
As Gabriel Kremmidiotis aptly summarizes, “Our mission is to support biotechs in bringing innovative oncology therapies to market by providing the highest level of scientific and operational excellence. Together, we can make a meaningful difference in the fight against cancer.”
Read more about Avance Clinical’s oncology capabilities.
